top of page

Profile

Join date: Oct 4, 2024

Posts (59)

Nov 16, 2026 ∙ 1 min
Prevalence of high probability of PH in early systemic sclerosis
In patients with early systemic sclerosis or systemic sclerosis without cutaneous involvement, 26% had a high probability of pulmonary hypertension (PH), most often pulmonary arterial hypertension. Screening for pulmonary hypertension early in the course of systemic sclerosis may help identify PH sooner. Read the Revista Colombiana de Reumatología (English edition) article

2
0
Nov 9, 2026 ∙ 1 min
Systematic review of treatment strategies to reach low-risk status in PH
A systematic review examined the evidence linking individual pulmonary hypertension treatment strategies to low-risk status and long-term outcomes. 48 reports were included. Few patients reached low-risk status. Prostacyclin pathway therapy and add-on sotatercept improved clinical outcomes. Low-risk status predicted survival, but people initially at low risk did not often stay low risk: the risk category at their first annual review predicted the later disease course. Studies disagreed on...

2
0
Nov 2, 2026 ∙ 1 min
Using antithrombotics in children with PH
A study used US registry data and a survey to explore the usage of antithrombotic therapy in children with pulmonary hypertension (PH). Antithrombotic therapy is used infrequently in pediatric PH and is primarily reserved for high-risk patients, with significant variation across centers. Survey data generally agreed that antithrombotic therapy was not indicated for patients at the lowest risk and was probably indicated for patients at the highest risk, but management of intermediate-risk...

2
0

PHA Canada

408 - 55 Water Street

Office 8928

Vancouver, BC, V6B 1A1

Email: info@phacanada.ca

Phone: 604-682-1036

Toll Free: 1-877-774-2226

Charitable Registration # 872050224RR0001

  • Instagram
  • Facebook
  • X
  • LinkedIn
  • Youtube

Copyright 2025 PHA CANADA, ALL RIGHTS RESERVED   |   Website created by Creativibe

bottom of page